Jan 22, 2020
CMRC: Abdullah, an Emirati Youth, a Beacon of Hope and a Success Story
Dec 16, 2019
BOTOX® (onabotulinumtoxinA) Celebrates 30 Years of Endless Innovation
Aug 13, 2019
Feinstein Institutes trial finds promising non-invasive therapy for stroke
Jun 21, 2019
FDA Approves BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
Jun 17, 2019
Neurana Pharmaceuticals Announces Completion of Enrollment in the Phase 2 Study of Tolperisone in Acute Muscle Spasms of the Back
Jun 05, 2019
Ipsen's Dysport® (Clostridium Botulinum Type a Toxin-haemagglutinin Complex) Becomes First and Only Botulinum Toxin Type A to be Granted a Licence Update for Administration by Healthcare Professionals, Such as Physiotherapists, in the UK
Mar 29, 2019
Global Spasticity Treatment Market 2019-2023 - Key Vendors are Allergan, F. Hoffmann-La Roche, Ipsen Pharma, Pfizer & UCB S.A.
Mar 07, 2019
FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Feb 08, 2019
PathMaker Neurosystems Announces Publication of Scientific Paper Establishing First Linkage Between Spasticity and Overexpression of a Specific Neuronal Cotransporter
Feb 04, 2019
Neurana Pharmaceuticals Announces First Patient Enrolled in the "STAR Study," a Phase 2 Dose Ranging Study of Tolperisone in Acute Muscle Spasms of the Back
Oct 31, 2018
PolyU Develops Robotic Arm for Self-help Mobile Rehabilitation for Stroke Patients
Aug 20, 2018
Electrophysiology Devices Market Growth Intensifies on Heels of Latest Technological Advancements
May 07, 2018
Neurana Pharmaceuticals Announces Completion of $60 Million Series A Financing